Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II)
Protein induced by vitamin K absence or antagonist II (PIVKA-II) is a putative-specific marker of hepatocellular carcinoma (HCC), but a small number of gastric cancers may also produce it. At present, Chinese and foreign guidelines have listed PIVKA 2 tumor marker as a significant indicator for liver cancer detection.
Details of PIVKA-II products as follows, and if you may have interest, we also provide a tumor markers list.
Related Immunoassays
Immunoassay News
- Similarities and Differences between the Approaching Procalcitonin (PCT) and Calcitonin (CT)
- Treatment Approaches for Triiodothyronine Antibody Related Thyroid Disorders
- The Bottleneck in the R&D of IVD Raw Materials Needs to Be Broken Through and the Competitiveness of the Industry Needs to Be Improved
- A brief analysis of the key points of IVDR
- Cardiac Markers
-
Tumor Marker
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
Human Chitinase 3-like 1
-
CEA
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
